http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02072169-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f978244d5c58f66e76cefd9436113df6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79a9e0dbf7d8c236429ad648ee580b20
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0612
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M11-005
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00
filingDate 2002-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6184d0c1f5acee70fac8f43d937ae326
publicationDate 2002-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-02072169-A2
titleOfInvention Ocular drug delivery nebulizer
abstract An ocular nebulizer (100) that comprises an ultrasonic horn (152) in fluid communication with a first substance source (104, or 154) for drawing a substance from the source. An ultrasonic oscillator (160) vibrates the horn (152) ultrasonically for nebulizing the substance from the horn exit. An eye cup (106) is configured for placement around an eye, and the horn exit (158) is disposed within the eyecup. The eye cup is configured for directing the nebulized substance towards the eye.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2609743-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9087145-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114129341-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11679028-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8733935-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114129341-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021322210-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10154923-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10073949-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8684980-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2517678-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10639194-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10646373-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11717845-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7883031-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9962534-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11398306-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10839960-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11011270-B2
priorityDate 2001-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5970974-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5630793-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6083922-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449160084
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665650

Total number of triples: 39.